An Overview of NovaVision® Vision Restoration Therapy (VRT)
VRT is a clinically proven, FDA-cleared technology designed to improve the quality of life of stroke and brain injury patients by restoring some of their lost vision. The therapy does not require surgery or medication of any kind.
More than 1,000 patients have been treated with VRT, and in a recent retrospective study more than 70 percent of patients who completed VRT showed measurable improvements in their vision, which enhanced their quality of life.
The VRT Process
- Patients contact NovaVision® or one of the centers offering the therapy to find out if VRT is appropriate.
- After completing an initial visit and reviewing the patient's medical and ophthalmologic records, the center will determine if an examination and VRT diagnostic testing is indicated.
- Diagnostic tests are performed and results are used to create a customized vision therapy.
- Patients receive their VRT medical device and first vision therapy module, usually at the center, and then take the device home to complete daily therapy sessions.
- Module results are sent by the patient to NovaVision® for evaluation, and updates to the vision therapy are made in order to optimize the progress.
- After the initial six to seven month course of vision therapy, it may be recommended that the patient continues therapy.
VRT Tips and Useful Information
- Patients complete daily sessions six days a week. It is important to consistently perform the vision therapy to receive optimal results.
- Caregivers are a great resource of support to patients during the VRT rehabilitation program and encouragement is important to a patient's vision therapy compliance.
- Taking extended breaks while performing therapy reduces the effectiveness of the daily regimen. Take advantage of VRT by practicing recommended VRT processes.
- Patients should be in a comfortable environment when performing VRT, as this improves the ability to focus on the therapy process.
- Vision therapy results vary from patient to patient. Patients should not become discouraged if improvements do not occur in the first few months, or if improvements are gradual.
- Stopping the treatment after the initial phase of therapy will not cause patients to lose the sight they have gained.
